201 related articles for article (PubMed ID: 22785516)
1. Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT.
Chong A; Song HC; Oh JR; Ha JM; Min JJ; Bom HS; Choi YD; Lee JS
Clin Nucl Med; 2012 Aug; 37(8):798-800. PubMed ID: 22785516
[TBL] [Abstract][Full Text] [Related]
2. Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer.
Yoo SW; Song HC; Oh JR; Kim J; Kang SR; Chong A; Byun BH; Hong SP; Min JJ; Bom HS
Clin Nucl Med; 2012 Jul; 37(7):682-3. PubMed ID: 22691513
[TBL] [Abstract][Full Text] [Related]
3. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
4. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Avery R; Kuo PH
Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
[TBL] [Abstract][Full Text] [Related]
5. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
7. Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.
Mojtahedi A; Solomon SB; Ulaner GA
Clin Nucl Med; 2013 Mar; 38(3):217-8. PubMed ID: 23357824
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma.
Cao Q; Lu M; Huebner T; Dilsizian V; Chen W
Clin Nucl Med; 2013 Sep; 38(9):e367-9. PubMed ID: 23856822
[TBL] [Abstract][Full Text] [Related]
9. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
10. Active Bone Marrow With Focal FDG Accumulation Mimicking Bone Metastasis With a Case of Early Esophageal Cancer.
Okuyama C; Sasaki N; Nishimura M; Matsushima S; Yoshimatsu R
Clin Nucl Med; 2018 Apr; 43(4):258-261. PubMed ID: 29504964
[TBL] [Abstract][Full Text] [Related]
11. Utility of 18F-FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient.
Lee EY; Leung AY; Anthony MP; Loong F; Khong PL
Am J Hematol; 2011 Dec; 86(12):1036-7. PubMed ID: 21800353
[No Abstract] [Full Text] [Related]
12. Intramedullary metastasis detected with 18F FDG-PET/CT.
Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
[No Abstract] [Full Text] [Related]
13. Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Adams HJ; Kwee TC; Nievelstein RA
J Nucl Med; 2013 Nov; 54(11):2017-8. PubMed ID: 24009274
[No Abstract] [Full Text] [Related]
14. Reply: Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
Berthet L; Humbert O; Cochet A
J Nucl Med; 2013 Nov; 54(11):2018. PubMed ID: 24029654
[No Abstract] [Full Text] [Related]
15. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
16. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
17. False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
Montini KM; Tulchinsky M
Clin Nucl Med; 2012 Mar; 37(3):307-10. PubMed ID: 22310266
[No Abstract] [Full Text] [Related]
18. Mediastinal germ cell tumor presenting with bone marrow metastases: an unusual pattern of relapse demonstrated with (18)F-FDG PET-CT.
Sharma P; Sudhir SK; Dhull VS; Jain TK; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):187-8. PubMed ID: 24076038
[No Abstract] [Full Text] [Related]
19. Antitumor effect of 89Sr for multiple bone metastases of breast cancer: diagnosis by 18F-FDG PET/CT.
Hama Y
Clin Nucl Med; 2014 Apr; 39(4):e290-1. PubMed ID: 23917785
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT demonstrating primary bone lymphoma of the extremities mimicking an inflammatory peripheral arthropathy.
Tachibana A; Robinson RJ; Patel CN
Clin Nucl Med; 2015 Feb; 40(2):169-71. PubMed ID: 25140543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
